Class II Alloantibody and Mortality in Simultaneous Liver-Kidney Transplantation-Reference-Cited by-同舟云学术

Class II Alloantibody and Mortality in Simultaneous Liver-Kidney Transplantation

Author:

O'Leary J. G.¹,Gebel H. M.²,Ruiz R.¹,Bray R. A.²,Marr J. D.¹,Zhou X. J.³,Shiller S. M.³,Susskind B. M.¹,Kirk A. D.⁴,Klintmalm G. B.¹

Affiliation:

1. Annette C. & Harold C. Simmons Transplant Institute, Baylor University Medical Center; Dallas TX

2. Department of Pathology and Laboratory Medicine; Emory University; Atlanta GA

3. Department of Pathology, Baylor University Medical Center; Dallas TX

4. Department of Surgery, Emory University; Atlanta GA

Publisher

Wiley

Subject

Pharmacology (medical),Transplantation,Immunology and Allergy

Link

Reference14 articles.

3. Positive crossmatch in primary human liver allografts under cyclosporine or FK 506 therapy;Takaya;Transplant Proc,1991

4. Significance of a positive crossmatch on outcome in human liver transplantation;Ogura;Transplant Proc,1992

Cited by 88 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献